Lasso and CMI Media Group are the first to successfully leverage IBM Watson’s dynamic creative capabilities for healthcare marketing, driving media performance 40% above benchmark.
Tag Archive for: healthcare marketing
A 16-year veteran at Digitas Health, Geoff Thorne will focus on enhancing the company’s technology and strategy offerings to solve complex challenges for its biopharmaceutical, medical technology, and wellness clients.
VMLY&R’s Walter Geer shares his take on the industry’s progress over the past several decades, and the importance of technology, brand authenticity, patient access and much more.
Kristine Wobschall and Sonal Adhav reinforce the agency’s client experience and medical affairs practices.
Creative & broadcast talent from across U.S. and Canada continue to flock to Klick to create work that makes a difference and be part of large indie health agency’s renowned culture. The agency also announced Klick Brands, Studio K, and Klick Influence to elevate life sciences clients’ brands and content in quickly evolving marketplace.
The greatest power of the new marketing technologies available to pharma brands may be their capacity to bring the beliefs and questions of real patients and HCPs into sharper view.
Dennis Urbaniak, executive vice president digital therapeutics at Orexo US and Jay Carter, EVP, director of business development at AbelsonTaylor expand on this important and complex question.
Achieving genuine human connection is a crucial part of survival. We all want to feel seen and heard, whether it’s on a casual level during a conversation about work, or on a humorous level exchanging the adventures of parenting, or at the very deep level of discussing and sharing mental health challenges. When it comes down to it, we want to be understood and supported, not necessarily by everyone we know but by the people who matter to us most. We want – we need – empathy. And when it comes to health, and managing the healthcare journey, this concept is no different.
The long-awaited digital transformation of life sciences has arrived. It went from a promise to a need.
More than 90 percent of rare diseases have no FDA-approved treatment, and it can take seven to eight years just to get diagnosed. It’s a zero-sum game for marketers because we’re walking onto an empty field full of people desperate for someone to join their team. We have the opportunity to make a substantial impact in the small towns of rare disease.